FDA Inspection
New York Blood Center IncNew York Blood Center Inc – FDA Inspection, Sep 30, 2015
Record Details
This FDA Inspection record concerns New York Blood Center Inc, with an inspection on September 30, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- New York Blood Center Inc
- Inspection Date
- September 30, 2015
- Product Type
- Biologics
View Company Profile
ID · 7a8ea54b-29a4-4dd6-b77d-664dba985eb4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 946194
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of New York Blood Center Inc
9| Date | Classification | Office | Project area |
|---|---|---|---|
| September 16, 2025 | Not classified | Minneapolis District Office | |
| November 15, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 20, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 17, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 13, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for New York Blood Center Inc
- FDA Inspection 1284932 - 2025-09-16
- FDA Inspection 1254640 - 2024-11-15
- FDA Inspection 1097900 - 2019-06-20
- FDA Inspection 1004777 - 2017-03-17
- FDA Inspection 861409 - 2013-11-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.